Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Keywords
- Endocrine Cell
- Intramyocellular Lipid
- Congenital Generalize Lipodystrophy
- Nonadipose Tissue
- Lipotoxic Cardiomyopathy
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Unger RH. Longevity, lipotoxicity and leptin: The adipocyte defense against feasting and famine. Biochimie 2005;87:57–64.
Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005;1734:112–126.
Listenberger LL, Han H, Lewis SE, et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA 2003;100:3077–3082.
DeFronzo RA. Dysfunctional fat cells, lipotoxicity and type 2 diabetes. Int J Clin Pract 2004;(Suppl):9–21.
Unger RH. Lipotoxic diseases. Annu Rev Med 2002;53:319–336.
Charriere G, Cousin B, Arnaud E, et al. Preadipocyte conversion to macrophage. J Biol Chem 2003;278:9850–9855.
Civelek VN, Hamilton JA, Tornheim K, et al. Intracellular pH in adipocytes: Effects of free fatty acid diffusion across the plasma membrane, lipolytic agonists, and insulin. Proc Natl Acad Sci USA 1996;93:10139–10144.
Petschow BW, Batema RP, Ford LL. Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 1996;40:302–306.
Coonrod JD. Role of surfactant free fatty acids in antimicrobial defenses. Eur J Resp Dis 1987;153(Suppl):209–214.
Akaki T, Sato K, Shimizu T, et al. Effector molecules in expression of the antimicrobial activity of macrophages against Mycobacterium avium complex: Roles of reactive nitrogen intermediates, reactive oxygen intermediates, and free fatty acids. J Leukoc Biol 1997;62:795–804.
Akaki T, Tomioka H, Shimizu T, et al. Comparative roles of free fatty acids with reactive nitrogen intermediates and reactive oxygen intermediates in expression of the antimicrobial activity of macrophages against Mycobacterium tuberculosis. Clin Exp Immunol 2000;121:302–310.
Maurin AC, Chavassieux PM, Vericel E, et al. Role of polyunsaturated fatty acids in the inhibitory effect of human adipocytes on osteoblastic proliferation. Bone 2002;31:260–266.
Sharma S, Adrogue JV, Golfman L, et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004;18:1692–1700.
Goodpaster BH, Theriault R, Watkins SC, et al. Intramuscular lipid content is increased in obesity and decreased by weight loss. Metabolism 2000;49:467–472.
Szczepaniak LS, Dobbins RL, Metzger GJ, et al. Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003;49:417–423.
Peterson LR, Herrero P, Schechtman KB, et al. Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women. Circulation 2004;109:2191–2196.
Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: Validation in vivo. Am J Physiol 1999;276:E977–989.
Bajaj M, Suraamornkul S, Kashyap S, et al. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. J Clin Endocrinol Metab 2004;89:4649–4655.
Lelliott C, Vidal-Puig AJ. Lipotoxicity, an imbalance between lipogenesis de novo and fatty acid oxidation. Int J Obes Relat Metab Disord 2004;28(Suppl 4):S22–S28.
Kirkland JL, Tchkonia T, Pirtskhalava T, et al. Adipogenesis and aging: Does aging make fat go MAD? Exp Gerontol 2002;37:757–767.
Unger RH. Lipid overload and overflow: Metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003;14:398–403.
Rodriguez A, Muller DC, Engelhardt M, et al. Contribution of impaired glucose tolerance in subjects with the metabolic syndrome: Baltimore Longitudinal Study of Aging. Metabolism 2005;54:542–547.
Agarwal AK, Barnes RI, Garg A. Genetic basis of congenital generalized lipodystrophy. Int J Obes Relat Metab Disord 2004;28:336–339.
Ogawa A, Johnson JH, Ohneda M, et al. Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J Clin Invest 1992;90:497–504.
Dowell P, Flexner C, Kwiterovich PO, et al. Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors. J Biol Chem 2000;275:41325–41332.
Grinspoon SK. Metabolic syndrome and cardiovascular disease in patients with human immunodeficiency virus. Am J Med 2005;118(Suppl 2):23S–28S.
Chiu HC, Kovacs A, Ford DA, et al. A novel mouse model of lipotoxic cardiomyopathy. J Clin Invest 2001;107:813–822.
Felber JP, Ferrannini E, Golay A, et al. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 1987;36:1341–1350.
Kelley DE, Goodpaster B, Wing RR, et al. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol 1999;277:E1130–E1141.
Kelley DE, Goodpaster BH. Skeletal muscle triglyceride. An aspect of regional adiposity and insulin resistance. Diab Care 2001;24:933–941.
Jagasia D, McNulty PH. Diabetes mellitus and heart failure. Congest Heart Fail 2003;9:133–139.
Lee Y, Wang MY, Kakuma T, et al. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 2001;276:5629–5635.
Shimomura I, Hammer RE, Ikemoto S, et al. Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy. Nature 1999;401:73–76.
Oral EA, Simha V, Ruiz E, et al. Leptin-replacement therapy for lipodystrophy. New Engl J Med 2002;346:570–578.
Gavrilova B, Marcus-Samuels B, Graham D, et al. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 2000;105:271–278.
Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes 2004;53:1412–1417.
McGarry JD, Dobbins RL. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999;42:128–138.
Mazumder PK, O’Neill BT, Roberts MW, et al. Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. Diabetes 2004;53:2366–2374.
Carley AN, Semeniuk LM, Shimoni Y, et al. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function. Am J Physiol 2004;286:E449–E455.
Finck BN, Lehman JJ, Leone TC, et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002;109:121–130.
Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001;276:14890–14895.
Unger RH. The physiology of cellular liporegulation. Annu Rev Physiol 2003;65:333–347.
Russell AP, Gastaldi G, Bobbioni-Harsch E, et al. Lipid peroxidation in skeletal muscle of obese as compared to endurance-trained humans: A case of good vs. bad lipids? FEBS Lett 2003;551:104–106.
MacDonald GA, Bridle KR, Ward PJ, et al. Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol 2001;16:599–606.
Wrede CE, Dickson LM, Lingohr MK, et al. Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). J Biol Chem 2002;277:49676–49684.
Yaney GC, Korchak HM, Corkey BE. Long-chain acyl CoA regulation of protein kinase C and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells. Endocrinology 2000;141:1989–1998.
Griffin ME, Marcucci MJ, Cline GW, et al. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999;48:1270–1274.
Kim YB, Shulman GI, Kahn BB. Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda/zeta but not on glycogen synthase kinase-3. J Biol Chem 2002;277:32915–32922.
Shimabukuro M, Zhou YT, Levi M, et al. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci USA 1998;95:2498–2502.
Cnop M, Hannaert JC, Hoorens A, et al. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 2001;50:1771–1777.
Aronis A, Madar Z, Tirosh O. Mechanism underlying oxidative stress-mediated lipotoxicity: Exposure of J774.2 macrophages to triacylglycerols facilitates mitochondrial reactive oxygen species production and cellular necrosis. Free Radical Biol Med 2005;38:1221–1230.
de Vries JE, Vork MM, Roemen TH, et al. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997;38:1384–1394.
Maedler K, Spinas GA, Dyntar D, et al. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 2001;50:69–76.
Hardy S, Langelier Y, Prentki M. Oleate activates phosphatidylinositol 3-kinase and promotes proliferation and reduces apoptosis of MDA-MB-231 breast cancer cells, whereas palmitate has opposite effects. 2000;60:6353–6358.
Paumen MB, Ishida Y, Muramatsu M, et al. Inhibition of carnitine palmitoyltransferase I augments sphingolipid synthesis and palmitate-induced apoptosis. J Biol Chem 1997;272:3324–3329.
Shimabukuro M, Higa M, Zhou YT, et al. Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 1998;273:32487–32490.
Shimabukuro M, Ohneda M, Lee Y, et al. Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest 1997;100:290–295.
Ostrander DB, Sparagna GC, Amoscato AA, et al. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem 2001;276:38061–38067.
Shimabukuro M, Wang MY, Zhou YT, et al. Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci USA 1998;95:9558–9561.
Hufnagel B, Dworak M, Soufi M, et al. Unsaturated fatty acids isolated from human lipoproteins activate protein phosphatase type 2Cbeta and induce apoptosis in endothelial cells. Atherosclerosis 2005;180:245–254.
Zhu Y, Schwarz S, Ahlemeyer B, et al. Oleic acid causes apoptosis and dephosphorylates Bad. Neurochem Int 2005;46:127–135.
Kharroubi I, Ladriere L, Cardozo AK, et al. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: Role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004;145:5087–5096.
Artwohl M, Roden M, Waldhausl W, et al. Free fatty acids trigger apoptosis and inhibit cell cycle progression in human vascular endothelial cells. FASEB J 2003;18:146–148.
Lupi R, Dotta F, Marselli L, et al. Prolonged exposure to free fatty acids has cytostatic and pro-apoptotic effects on human pancreatic islets: Evidence that beta-cell death is caspase mediated, partially dependent on ceramide pathway, and Bcl-2 regulated. Diabetes 2002;51:1437–1442.
Guo W, Pirtskhalava T, Tchkonia T, et al. Aging results in paradoxical susceptibility of fat cell progenitors to lipotoxicity. Obesity Res 2004;12(Suppl):A31.
Chawla A, Lee CH, Barak Y, et al. PPAR delta is a very low-density lipoprotein sensor in macrophages. Proc Natl Acad Sci USA 2003;100:1268–1273.
Shimabukuro M, Koyama K, Lee Y, et al. Leptin-or troglitazone-induced lipopeniaprotects islets frominterleukin 1beta toxicity. J Clin Invest 1997;100:1750–1754.
Manco M, Calvani M, Mingrone G. Effects of dietary fatty acids on insulin sensitivity and secretion. Diabetes Obes Metab 2004;6:402–413.
Nielsen LB, Bartels ED, Bollano E. Overexpression of apolipoprotein B in the heart impedes cardiac triglyceride accumulation and development of cardiac dysfunction in diabetic mice. J Biol Chem 2002;277:27014–27020.
Yokoyama M, Yagyu H, Hu Y, et al. Apolipoprotein B production reduces lipotoxic cardiomyopathy: Studies in heart-specific lipoprotein lipase transgenic mouse. J Biol Chem 2004;279:4204–4211.
Foufelle F, Ferre P. New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: A role for the transcription factor sterol regulatory element binding protein-1c. Biochem J 2002;366 (Pt 2):377–391.
Gordon E. Non-esterified fatty acids in the blood of obese and lean subjects. Am J Clin Nutr 1960;8:740–747.
Reaven GM, Hollenbeck C, Jeng CY, et al. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes 1988;37:1020–1024.
Maslowska M, Vu H, Phelis S, et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 1999;29:679–686.
Unger RH, Orci L. Lipotoxic diseases of nonadipose tissues in obesity. Int J Obes Relat Metab Disord 2000;24(Suppl 4):S28–S32.
Goodpaster BH, He J, Watkins S, et al. Skeletal muscle lipid content and insulin resistance: Evidence for a paradox in endurance-trained athletes. J Clin Endocrinol Metab 2001;86:5755–5761.
Combs TP, Wagner JA, Berger J, et al. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: A potential mechanism of insulin sensitization. Endocrinology 2002;143:998–1007.
Addy CL, Gavrila A, Tsiodras S, et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab 2003;88:627–636.
Thamer C, Machann J, Tschritter O, et al. Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res 2002;34:646–649.
Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57–58.
Tomas E, Tsao TS, Saha AK, et al. Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: Acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci USA 2002;99:16309–16313.
Minokoshi Y, Kim Y, Peroni O, et al. Leptin stimulates fatty acid oxidation by activating AMP-activated protein kinase. Nature 2002;415:339–343.
Lee Y, Naseem RH, Duplomb L, et al. Hyperleptinemia prevents lipotoxic cardiomyopathy in acyl CoA synthase transgenic mice. Proc Natl Acad Sci USA 2004;101(37):13624–13629.
Tomas E, Kelly M, Xiang X, et al. Metabolic and hormonal interactions between muscle and adipose tissue. Proc Nutr Soc 2004;63:381–385.
Minokoshi Y, Kahn BB. Role of AMP-activated protein kinase in leptin-induced fatty acid oxidation in muscle. Biochem Soc Trans 2003;31 (Pt 1):196–201.
Saha AK, Avilucea PR, Ye JM, et al. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo. Biochem Biophys Res Commun 2004;314:580–585.
Fryer LG, Parbu-Patel A, Carling D. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J Biol Chem 2002;277:25226–25232.
Iglesias MA, Ye JM, Frangioudakis G, et al. AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes 2002;51:2886–2894.
Yu X, McCorkle S, Wang M, et al. Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: Prevention of diabetes and ectopic lipid deposition. Diabetologia 2004;47:2012–2021.
Kim JK, Fillmore JJ, Chen Y, et al. Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci USA 2001;98:7522–7527.
Hanada K. Serine palmitoyltransferase, a key enzyme of sphingolipid metabolism. Biochim Biophys Acta 2003;1632:16–30.
Picard F, Kurtev M, Chung N, et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 2004;430:921.
Lundgren M, Eriksson JW. No in vitro effects of fatty acids on glucose uptake, lipolysis or insulin signaling in rat adipocytes. Horm Metab Res 2004;36:203–209.
Grimaldi PA, Knobel SM, Whitesell RR, et al. Induction of aP2 gene expression by nonmetabolized long-chain fatty acids. Proc Natl Acad Sci USA 1992;15:10930–10934.
Coe NR, Simpson MA, Bernlohr DA. Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels. J Lipid Res 1999;40:967–972.
Bertrand HA, Masoro EJ, Yu BP. Increasing adipocyte number as the basis for perirenal depot growth in adult rats. Science 1978;201:1234–1235.
Das K, Lewis RY, Combatsiaris TP, et al. Predominant expression of the mitochondrial dicarboxylate carrier in white adipose tissue. Biochem J 1999;344 (Pt 2):313–320.
Lin Y, Berg AH, Iyengar P, et al. The hyperglycemia-induced inflammatory response in adipocytes: The role of reactive oxygen species. J Biol Chem 2005;280:4617–4626.
Lu B, Ennis D, Lai R, et al. Enhanced sensitivity of insulin-resistant adipocytes to vanadate is associated with oxidative stress and decreased reduction of vanadate (+5) to vanadyl (+4). J Biol Chem 2001;276:35589–35598.
Talior I, Tennenbaum T, Kuroki T, et al. PKC-delta-dependent activation of oxidative stress in adipocytes of obese and insulin-resistant mice: Role for NADPH oxidase. Am J Physiol 2005;288:E405–E411.
Carriere A, Fernandez Y, Rigoulet M, et al. Inhibition of preadipocyte proliferation by mitochondrial reactive oxygen species. FEBS Lett 2003;550:163–167.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tchkonia, T., Corkey, B.E., Kirkland, J.L. (2006). Current Views of the Fat Cell as an Endocrine Cell: Lipotoxicity. In: Bray, G.A., Ryan, D.H. (eds) Overweight and the Metabolic Syndrome. Endocrine Updates, vol 26. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-32164-6_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-32164-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-32163-9
Online ISBN: 978-0-387-32164-6
eBook Packages: MedicineMedicine (R0)